Invention Grant
US08865897B2 Crystal modifications-3-(1H-indol-3-yl)-4- [4-methyl-piperazin-1-yl)-quinazolin-4-yl] -pyrrole-2, 5-D ione
有权
晶体修饰3-（1H-吲哚-3-基）-4- [4-甲基 - 哌嗪-1-基） - 喹唑啉-4-基] - 吡咯-2,5-D离子
![Crystal modifications-3-(1H-indol-3-yl)-4- [4-methyl-piperazin-1-yl)-quinazolin-4-yl] -pyrrole-2, 5-D ione](/docs/US/2014-10-21/US08865897B2/abs.jpg.600x600.jpg)
- Patent Title: Crystal modifications-3-(1H-indol-3-yl)-4- [4-methyl-piperazin-1-yl)-quinazolin-4-yl] -pyrrole-2, 5-D ione
- Patent Title (中): 晶体修饰3-（1H-吲哚-3-基）-4- [4-甲基 - 哌嗪-1-基） - 喹唑啉-4-基] - 吡咯-2,5-D离子
-
Application No.: US12445371Application Date: 2007-10-18
-
Publication No.: US08865897B2Publication Date: 2014-10-21
- Inventor: Piotr Karpinski , Stéphanie Monnier , Elias Ndzie , Dimitris Papoutsakis , Paul A Sutton
- Applicant: Piotr Karpinski , Stéphanie Monnier , Elias Ndzie , Dimitris Papoutsakis , Paul A Sutton
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Jennifer Chapman
- International Application: PCT/US2007/022241 WO 20071018
- International Announcement: WO2008/051440 WO 20080502
- Main IPC: C07D403/14
- IPC: C07D403/14
![Crystal modifications-3-(1H-indol-3-yl)-4- [4-methyl-piperazin-1-yl)-quinazolin-4-yl] -pyrrole-2, 5-D ione](/abs-image/US/2014/10/21/US08865897B2/abs.jpg.150x150.jpg)
Abstract:
The invention relates to a new crystalline form of the acetate salt of which may be used, for example, for prevention or treatment of transplant rejection.
Public/Granted literature
Information query
